207 related articles for article (PubMed ID: 35758417)
1. Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain.
Podvin S; Jiang Z; Boyarko B; Rossitto LA; O'Donoghue A; Rissman RA; Hook V
ACS Chem Neurosci; 2022 Jul; 13(13):1992-2005. PubMed ID: 35758417
[TBL] [Abstract][Full Text] [Related]
2. Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry.
Hook V; Lietz CB; Podvin S; Cajka T; Fiehn O
J Am Soc Mass Spectrom; 2018 May; 29(5):807-816. PubMed ID: 29667161
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease.
Quinn JP; Ethier EC; Novielli A; Malone A; Ramirez CE; Salloum L; Trombetta BA; Kivisäkk P; Bremang M; Selzer S; Fournier M; Das S; Xing Y; Arnold SE; Carlyle BC
J Am Soc Mass Spectrom; 2023 Apr; 34(4):649-667. PubMed ID: 36912488
[TBL] [Abstract][Full Text] [Related]
4. Ser
Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A
Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667
[TBL] [Abstract][Full Text] [Related]
5. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH
Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692
[TBL] [Abstract][Full Text] [Related]
7. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of tau, beta-amyloid and beta-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study.
Shukla C; Bridges LR
Neuroreport; 1999 Dec; 10(18):3785-9. PubMed ID: 10716210
[TBL] [Abstract][Full Text] [Related]
10. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.
Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH
J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609
[TBL] [Abstract][Full Text] [Related]
11. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
12. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
[TBL] [Abstract][Full Text] [Related]
14. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
Cicognola C; Brinkmalm G; Wahlgren J; Portelius E; Gobom J; Cullen NC; Hansson O; Parnetti L; Constantinescu R; Wildsmith K; Chen HH; Beach TG; Lashley T; Zetterberg H; Blennow K; Höglund K
Acta Neuropathol; 2019 Feb; 137(2):279-296. PubMed ID: 30547227
[TBL] [Abstract][Full Text] [Related]
15. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
Muraoka S; DeLeo AM; Sethi MK; Yukawa-Takamatsu K; Yang Z; Ko J; Hogan JD; Ruan Z; You Y; Wang Y; Medalla M; Ikezu S; Chen M; Xia W; Gorantla S; Gendelman HE; Issadore D; Zaia J; Ikezu T
Alzheimers Dement; 2020 Jun; 16(6):896-907. PubMed ID: 32301581
[TBL] [Abstract][Full Text] [Related]
16. The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
Kvartsberg H; Lashley T; Murray CE; Brinkmalm G; Cullen NC; Höglund K; Zetterberg H; Blennow K; Portelius E
Acta Neuropathol; 2019 Jan; 137(1):89-102. PubMed ID: 30244311
[TBL] [Abstract][Full Text] [Related]
17. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
18. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
19. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptidomics Mass Spectrometry Reveals Signaling Networks Generated by Distinct Protease Pathways in Human Systems.
Hook V; Bandeira N
J Am Soc Mass Spectrom; 2015 Dec; 26(12):1970-80. PubMed ID: 26483184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
